no statement of use filed
on 21 Jan 2019
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
87074279 filed on 16th Jun 2016
Registration Number
N/A
Correspondent Address
Bruce W. Longbottom
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disordeRead More
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, sleep disorders, Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
No 87074279
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 22nd Jan 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 21st Jan 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| 12th Jun 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 11th Jun 2018 | EXTENSION 3 GRANTED |
| 07th Jun 2018 | TEAS EXTENSION RECEIVED |
| 07th Jun 2018 | EXTENSION 3 FILED |
| 23rd Nov 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 21st Nov 2017 | EXTENSION 2 FILED |
| 21st Nov 2017 | TEAS EXTENSION RECEIVED |
| 21st Nov 2017 | EXTENSION 2 GRANTED |
